Here, we report a case of pediatric BPDCN with a novel MYB::PAIP1 rearrangement that is sufficient and necessary to drive leukemogenesis in vivo using a syngeneic murine transplant model. The gene discussed is MYB; the disease is CD4+/CD56+ hematodermic neoplasm.